PAR2 THE TOTAL COST OF TREATMENT AND THE COST-EFFECTIVENESS OFVALDECOXIBVS DICLOFENAC IN THE TREATMENT OF PATIENTS WITH OSTEOARTHRITIS (OA) OF THE HIP AND/OR KNEE
Abstract
Authors
B von Scheele KH Davis L Gaffney L Niculescu KM Verburg